Lung Cancer Clinical Trials in Hangzhou
2 recruitingHangzhou, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Lung CancerNon-small Cell Lung Cancer
Daiichi Sankyo137 enrolled45 locationsNCT06644768
Recruiting
Phase 1
The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University8 enrolled1 locationNCT05735028